CN1739752A - 治疗糖尿病的葛根制剂 - Google Patents
治疗糖尿病的葛根制剂 Download PDFInfo
- Publication number
- CN1739752A CN1739752A CN 200510040582 CN200510040582A CN1739752A CN 1739752 A CN1739752 A CN 1739752A CN 200510040582 CN200510040582 CN 200510040582 CN 200510040582 A CN200510040582 A CN 200510040582A CN 1739752 A CN1739752 A CN 1739752A
- Authority
- CN
- China
- Prior art keywords
- kudzu vine
- vine root
- poria
- root preparation
- radix puerariae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000010575 Pueraria lobata Nutrition 0.000 title claims abstract description 16
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 12
- 241000219781 Pueraria montana var. lobata Species 0.000 title 1
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 5
- 235000005903 Dioscorea Nutrition 0.000 claims description 3
- 241000234273 Dioscorea Species 0.000 claims description 3
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 235000004879 dioscorea Nutrition 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 230000008961 swelling Effects 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 238000002481 ethanol extraction Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 210000004153 islets of langerhan Anatomy 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 3
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000745390 Lophatherum Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 229930186706 Puerarin-xyloside Natural products 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 208000002479 balanitis Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007866 hepatic necrosis Effects 0.000 description 1
- 206010019692 hepatic necrosis Diseases 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- NAAXIGQVODQJOV-PXYOAQHISA-N puerarin xyloside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C(C1=C(C(C(C=2C=CC(O)=CC=2)=CO1)=O)C=C1)=C1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)CO1 NAAXIGQVODQJOV-PXYOAQHISA-N 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种治疗糖尿病的葛根制剂，其特征在于是由葛根与山药、茯苓、淡竹叶、薏苡仁、桑椹、百合等的一种或多种配制而成。其中的成分均为药食同源之中草药，可以长期服用，有效的调节人体阴阳平衡，逐步恢复人体胰岛功能，有效的控制、治疗各种并发症，摆脱人体对药物的长期依赖，对身体无副作用。
Description
技术领域
本发明涉及一种保健食品，具体地说是一种对糖尿病有治疗作用的葛根制剂。
背景技术
糖尿病是一种由遗传基因决定的全身慢性代谢性疾病。由于体内胰岛素的相对或绝对不足而引起糖、脂肪和蛋白质代谢的紊乱。其主要特点是高血糖及糖尿。典型症状可概括为“三多一少”，即多尿、多饮、多食和体重减轻。由于排尿功能增加，肾囊可能膨胀出现腰痛。有的病人因病情控制不好可因眼晶状体渗透压改变出现视物模糊。有些病人可由尿糖刺激引起外阴搔痒，男性可有阴茎头炎，发生尿痛。部分病人可有乏力、多汗、心慌、手抖、饥饿等低血糖反应。通常病人还易发生皮肤疖肿以及其它感染。目前的糖尿病尚没有特效药，且西药多数具有副作用，患者难以长期服用；中药效果不彰，难以控制病情发展。
发明内容
本发明的目的是提供一种对糖尿病有一定治疗作用的保健食品，但食品中的成分均为药食同源之中草药，可以长期服用，有效的调节人体阴阳平衡，逐步恢复人体胰岛功能，有效的控制、治疗各种并发症，摆脱人体对药物的长期依赖，对身体无副作用。
本发明的技术方案为：
一种治疗糖尿病的葛根制剂，其特征在于是由葛根与山药、茯苓、淡竹叶、薏苡仁、桑椹、百合中的一种或多种配制而成。
所述的葛根制剂，其特征在于各组分的重量配方为：
葛根 15-30 山药 15-30 茯苓10-15 淡竹叶 10-15
薏苡仁 10-15 桑椹 10-15 百合 10-15。
所述的葛根制剂，其特征在于各组分的重量配方为：
葛根 30 山药 30 茯苓10 淡竹叶 15
薏苡仁 10 桑椹 15 百合10。
所述的葛根制剂，其特征在于各组分的入药方式为：所述的葛根采用70％乙醇提取有效成分，山药、茯苓、薏苡仁采用粉碎细粉，百合、桑椹、淡竹叶采用水提取物，制剂形式为颗粒剂、粉剂、片剂、胶囊剂、膨化剂。
本发明组方中，茯苓有利尿作用，可使尿量及Na+、K+排出量增加，其促钠排出的有效成分为茯苓酸。茯苓具免疫增强作用和抗肿瘤作用，还有镇静，降血糖等作用。茯苓可松弛消化道平滑肌、抑制胃酸分泌。防止肝细胞坏死，体外还具有抗菌作用；山药补中益气，健脾止泻，益肺固精，止带缩尿；淡竹叶功用除烦热，清心火，利小便，外感风热，热淋，小便涩痛，主治心烦、尿赤、小便不利、口糜舌疮、牙龈肿痛；百合具有养阴润肺止咳清心安神功效，用于热病余热未清，虚烦惊悸，失眠多梦等。薏苡仁能健脾渗湿，除痹止泻，清热排浓，用于水肿，脚气，小便不利，湿痹拘挛，脾虚泄泻，肺痈，肠痈；扁平疣：葛根含葛根素、葛根素木糖甙、大豆黄酮、大豆黄酮甙及β谷甾醇、花生酸，具有降血脂、血压、血糖方面有较好疗效，是治疗心绞痛、心脑血管疾病，防止脑血栓，延缓衰老等作用：桑椹具有明目、聪耳、利五脏、治关节痛、止咳、化痰等药效。综合全方，药性平和，适合糖尿病人长期服用，对糖尿病对较好的辅助治疗作用。
具体实施方式
治疗糖尿病的葛根制剂，各组分的重量配方(Kg)为：
葛根 30 山药 30 茯苓 10 淡竹叶 15
薏苡仁 10 桑椹 15 百合 10。
以上组分，其中葛根采用70％乙醇等提取有效成分得葛粉，山药、茯苓、薏苡仁采用粉碎得细粉，百合、桑椹、淡竹叶用水提取，浓缩得浸膏，将上述各组分混合，再根据需要配合适当辅料制成颗粒剂、粉剂、片剂、胶囊剂、膨化剂。
质量标准为：
原料的质量规定：
葛根、山药、茯苓、淡竹叶、薏苡仁、桑椹、百合等原料质量标准参照中国药典一部规定执行。
产品的质量规定：
感官指标：灰白色、颗粒状或粉状、或片剂、或胶囊剂(胶囊剂的内容物为颗粒状或粉状)，无结块，无霉变，无杂质，无异味，呈本品自然香味。
理化指标：①蛋白质≥1.5％；②干燥失重≤10％；③铅(mg/Kg，以Pb计)≤0.5：④砷(mg/Kg，以As计)≤0.3；⑤葛根总黄酮含量：25±2.5mg/10g。
卫生指标：①细菌总数(cfu/g.ml)出厂≤500，销售≤1000；②大肠杆菌MPN(100g.ml)
出厂≤30，销售≤30；③霉菌(cfu/g.ml)出厂≤10，销售≤10；④酵母菌(cfu g.ml)
出厂≤10，销售≤10；⑤致病菌，出厂和销售时均不得检出。
Claims (4)
1、一种治疗糖尿病的葛根制剂，其特征在于是由葛根与山药、茯苓、淡竹叶、薏苡仁、桑椹、百合中的一种或多种配制而成。
2、根据权利要求1所述的葛根制剂，其特征在于各组分的重量配方为：
葛根15-30 山药15-30 茯苓10-15 淡竹叶10-15
薏苡仁10-15 桑椹10-15 百合10-15。
3、根据权利要求1所述的葛根制剂，其特征在于各组分的重量配方为：
葛根30 山药30 茯苓10 淡竹叶15
薏苡仁10 桑椹15 百合10。
4、根据权利要求1所述的葛根制剂，其特征在于各组分的入药方式为：所述的葛根采用70％乙醇提取有效成分，山药、茯苓、薏苡仁采用粉碎细粉，百合、桑椹、淡竹叶采用水提取物，制剂形式为颗粒剂、粉剂、片剂、胶囊剂、膨化剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100405827A CN100475257C (zh) | 2005-06-15 | 2005-06-15 | 治疗糖尿病的葛根制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100405827A CN100475257C (zh) | 2005-06-15 | 2005-06-15 | 治疗糖尿病的葛根制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1739752A true CN1739752A (zh) | 2006-03-01 |
| CN100475257C CN100475257C (zh) | 2009-04-08 |
Family
ID=36092377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100405827A Expired - Fee Related CN100475257C (zh) | 2005-06-15 | 2005-06-15 | 治疗糖尿病的葛根制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100475257C (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361929B (zh) * | 2008-08-23 | 2010-12-15 | 宫兆荣 | 治疗小儿麻疹初起的中药组方 |
| CN101543280B (zh) * | 2008-10-14 | 2011-06-29 | 汪永辉 | 一种山药营养粉 |
| CN102988726A (zh) * | 2012-10-13 | 2013-03-27 | 慈溪市锐玛电子有限公司 | 一种用于治疗糖尿病的药物 |
| CN103768335A (zh) * | 2014-02-25 | 2014-05-07 | 牛正华 | 一种对糖尿病具有治疗、保健作用的类糖酶茶粉冲剂 |
| CN105219602A (zh) * | 2015-10-21 | 2016-01-06 | 江南大学 | 一种降血糖葛根黄酒及其制备方法 |
| CN106620374A (zh) * | 2015-10-31 | 2017-05-10 | 边海云 | 一种调节2型糖尿病的中药组合物 |
| CN106728701A (zh) * | 2017-02-27 | 2017-05-31 | 普洱淞茂滇草六味制药股份有限公司 | 一种治疗糖尿病的药物组合物及其制备方法、制剂与应用 |
-
2005
- 2005-06-15 CN CNB2005100405827A patent/CN100475257C/zh not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361929B (zh) * | 2008-08-23 | 2010-12-15 | 宫兆荣 | 治疗小儿麻疹初起的中药组方 |
| CN101543280B (zh) * | 2008-10-14 | 2011-06-29 | 汪永辉 | 一种山药营养粉 |
| CN102988726A (zh) * | 2012-10-13 | 2013-03-27 | 慈溪市锐玛电子有限公司 | 一种用于治疗糖尿病的药物 |
| CN102988726B (zh) * | 2012-10-13 | 2014-11-26 | 慈溪市锐玛电子有限公司 | 一种用于治疗糖尿病的药物 |
| CN103768335A (zh) * | 2014-02-25 | 2014-05-07 | 牛正华 | 一种对糖尿病具有治疗、保健作用的类糖酶茶粉冲剂 |
| CN105219602A (zh) * | 2015-10-21 | 2016-01-06 | 江南大学 | 一种降血糖葛根黄酒及其制备方法 |
| CN106620374A (zh) * | 2015-10-31 | 2017-05-10 | 边海云 | 一种调节2型糖尿病的中药组合物 |
| CN106728701A (zh) * | 2017-02-27 | 2017-05-31 | 普洱淞茂滇草六味制药股份有限公司 | 一种治疗糖尿病的药物组合物及其制备方法、制剂与应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100475257C (zh) | 2009-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100475257C (zh) | 治疗糖尿病的葛根制剂 | |
| CN108295211A (zh) | 一种治疗糖尿病的药食同源食品组方及其制备方法 | |
| CN101297889B (zh) | 治疗口蹄疫的中药制剂及其制备方法 | |
| CN101450095A (zh) | 一种具有降血糖功能的药物组合物及其制备方法 | |
| CN1331502C (zh) | 一种中药组合物 | |
| CN1109553C (zh) | 治疗糖尿病的中药胶囊剂 | |
| CN107582845A (zh) | 一种预防和治疗糖尿病的植物粉 | |
| CN101549077B (zh) | 用于综合治疗小儿腹泻的中药制剂 | |
| CN102552743A (zh) | 一种用于治疗糖尿病的药物组合物及其制备方法 | |
| CN1052894C (zh) | 胃肠道促动力中药 | |
| CN1061538C (zh) | 治疗胃病的中成药 | |
| CN1418692A (zh) | 滋阴润燥降糖口服液及其制备方法 | |
| CN105994741A (zh) | 一种清淤消脂排毒养颜保健茶 | |
| CN1301725C (zh) | 一种治疗糖尿病的根粉消渴胶囊 | |
| CN1081464C (zh) | 用于治疗急慢性腹泻、赤白痢、急慢性结肠炎的中药 | |
| CN101491668A (zh) | 一种具有降血糖功能的组合物及其制备方法 | |
| CN104474103A (zh) | 一种天然植物降糖剂及其制备方法 | |
| CN1742963A (zh) | 一种治疗糖尿病和肾炎的中药 | |
| CN1201769C (zh) | 治疗糖尿病、肾病的药物 | |
| CN1098299A (zh) | 用于复发性口疮及各类口疮的甜凉口疮散及其配制方法 | |
| CN101843738A (zh) | 一种治疗糖尿病足的中药 | |
| CN1593617A (zh) | 一种通便排毒、养颜美容的中成药 | |
| CN106138310A (zh) | 用微量元素保健品和中药治疗ⅱ型糖尿病的方法 | |
| CN1879753A (zh) | 一种治疗肾脾两虚挟血瘀型糖尿病的药物 | |
| CN1727000A (zh) | 一种治疗胃病的中药制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HEFEI XINCHENG TRADITIONAL CHINESE MEDICINE RESEAR Free format text: FORMER OWNER: WANG XIAOSHAN Effective date: 20140324 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 230022 HEFEI, ANHUI PROVINCE TO: 230001 HEFEI, ANHUI PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140324 Address after: 230001 room 20, building 302, Zhongxing West Lake garden, Shuang seven road, Yaohai District, Anhui, Hefei Patentee after: Hefei Xincheng Chinese Medicine Research Institute Co Ltd Address before: 1 No. 316, No. 230022, Mount Huangshan Road, Hefei, Anhui, 106 Patentee before: Wang Xiaoshan |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090408 Termination date: 20170615 |